Q77.5

Clinical Causes: Mutations in the SLC26A2 gene, responsible for producing a protein involved in sulfate transport essential for cartilage and bone development. Inherited genetic factors passed from carrier parents, following an autosomal recessive inheritance pattern.

Key Symptoms: Short stature with disproportionate limb and trunk sizes. Bowed legs and joint stiffness, especially in the knees and ankles. Cleft palate or other facial anomalies. Deformed ears with a prominent or irregular shape. Spinal deformities, such as kyphosis or scoliosis. Hand and foot deformities, including shortened fingers and toes. Caved-in chest (pectus excavatum), which may impact breathing. Potential issues with hearing or ear infections due to ear deformities.

Diagnosis Path: Diagnosis of diastrophic dysplasia generally involves a combination of clinical examination and genetic testing. Healthcare providers may observe characteristic physical features and growth patterns. Imaging studies like X-rays can reveal specific bone deformities and joint abnormalities associated with the condition. Confirmatory diagnosis often requires genetic testing to identify mutations in the SLC26A2 gene.

Treatment Protocols: There is no cure for diastrophic dysplasia; management focuses on improving quality of life and addressing specific health concerns. Treatment approaches may include: - **Orthopedic interventions**: Surgery or casting to correct limb deformities or spinal curvature. - **Physical therapy**: Exercises to enhance mobility, joint flexibility, and muscle strength. - **Assistive devices**: Braces, orthotics, or mobility aids to support movement. - **Hearing management**: Devices or therapies to address hearing impairments. - **Regular monitoring**: Ongoing assessments to detect and treat related health issues promptly. Multidisciplinary care involving orthopedic specialists, genetic counselors, audiologists, and other healthcare professionals can help optimize outcomes for individuals with diastrophic dysplasia.